Pathogenic NALCN variants in humans are associated with severe hypotonia, speech impairment, cognitive delay [59], chronic constipation, and facial dysmorphism reminiscent of infantile hypotonia with psychomotor retardation and characteristic faces (IHPRF, OMIM #615419). Here, NALCN is linked to Global developmental delay.